Treatment of Diffuse Tracheobronchial Amyloidosis by Repeated Electrocautry Under Fiberoptic Bronchoscopy

1995 ◽  
Vol 42 (2) ◽  
pp. 250 ◽  
Author(s):  
Hojoong Kim ◽  
Jong Hoon Koh ◽  
Myeong Jun Chang ◽  
Sung Hun Hong ◽  
Kyung Hwan Kim ◽  
...  
2010 ◽  
Vol 30 (1) ◽  
pp. 80-83 ◽  
Author(s):  
Jin-jun BIAN ◽  
Jia-feng WANG ◽  
Xiao-jian WAN ◽  
Ke-ming ZHU ◽  
Xiao-ming DENG

2013 ◽  
Vol 32 (10) ◽  
pp. 1112-1115
Author(s):  
Sheng-chang WU ◽  
Ying ZHU ◽  
Jian XU ◽  
Yu-chao DONG ◽  
Qin-ying SUN ◽  
...  

2015 ◽  
Vol 36 (12) ◽  
pp. 1385
Author(s):  
Yuan YUAN ◽  
Sheng-nan REN ◽  
Xiao-yu GUO ◽  
Xiao-long MA ◽  
Jian-ping LU

2005 ◽  
Vol 40 (5) ◽  
pp. 392-397 ◽  
Author(s):  
Jorge L. Ramírez-Figueroa ◽  
Laura G. Gochicoa-Rangel ◽  
David H. Ramírez-San Juan ◽  
Mario H. Vargas

2021 ◽  
Vol 2021 (2) ◽  
Author(s):  
Feihong Ding ◽  
Yun Li ◽  
Shailesh Balasubramanian ◽  
Subha Ghosh ◽  
Jason N Valent ◽  
...  

ABSTRACT Amyloidosis is a heterogeneous group of diseases characterized by the extracellular deposition of misfolded proteins that can affect either systemically or locally confined to one system. Pulmonary amyloidosis is rare and can be classified into three forms according to the anatomic site of involvement: nodular pulmonary amyloidosis, tracheobronchial amyloidosis and diffuse alveolar-septal amyloidosis. The former two usually represent localized amyloid disease and the latter represents systemic disease. Typically lung parenchymal and tracheobronchial amyloidosis do not present together in localized forms of pulmonary amyloidosis. Here we report a unique case of localized pulmonary immunoglobulin light-chain amyloidosis, manifested as both parenchymal nodules and tracheobronchial amyloid deposition.


2021 ◽  
Vol 49 (5) ◽  
pp. 030006052110166
Author(s):  
Jiahui Chen ◽  
Chunhuan Chen ◽  
Wei Xu ◽  
Xiaoguang Zhang

Objective To collect computed tomography data of the laryngeal anatomy of Chinese men and to determine the feasibility of using the size 4 Ambu AuraOnce laryngeal mask (Ambu A/S, Copenhagen, Denmark) in Chinese men weighing >70 kg. Methods This prospective study involved men who underwent surgery from May 2018 to January 2019 at Jinshan Hospital. Pharyngeal and laryngeal parameters were measured by computed tomography. The laryngeal mask insertion success rate, requirement for tracheal tube insertion, laryngeal mask insertion time, fiberoptic bronchoscopy grading, air leakage pressure, and pharyngeal complications were analyzed. Results In a comparison of the size 4 and 5 Ambu AuraOnce devices, the first insertion success rate was 100% and 87% and the three-times insertion success rate was 100% and 93%, respectively, with no significant differences. However, the insertion time was significantly different at 19.6 ± 5.9 versus 31.1 ± 11.2 s, respectively, and the proportions of fiberoptic grading levels were also significantly different. There were no significant differences in the air leakage pressure or pharyngeal complications. Conclusion The size 4 Ambu AuraOnce is more adequate than the size 5 for Chinese men weighing >70 kg, with a shorter insertion time and higher fiberoptic bronchoscopic grading.


Sign in / Sign up

Export Citation Format

Share Document